Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Gaglia

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2014
Glycoprotein IIb/IIIa inhibitors increase bleeding: the elephant in the cardiac catheterization laboratoryMichael A Gaglia
Heart (British Cardiac Society)|July 25, 2014
Ticagrelor and the prevention of cardiovascular mortality: more than just platelet inhibition?Michael A Gaglia
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 17, 2017
Warfarin Prophylaxis for Anterior Infarction: Another Black Mark for Triple TherapyMichael A Gaglia
Circulation|January 19, 2011
Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelorMichael A Gaglia, Ron Waksman
Cardiovascular Therapeutics|March 30, 2010
Proton pump inhibitors and clopidogrelMichael A Gaglia, Ron Waksman
Evidence-Based Medicine|October 23, 2012
Lack of association between proton pump inhibitors and adverse events in patients taking clopidogrel and aspirinRon Waksman, Michael A Gaglia
European Heart Journal|August 2, 2011
Systematic review of thienopyridine discontinuation and its impact upon clinical outcomesMichael A Gaglia, Ron Waksman
Journal of Cardiovascular Pharmacology and Therapeutics|September 24, 2013
Cardiovascular pharmacology core reviews: aspirinMichael A Gaglia, Leonardo Clavijo
Human Vaccines|October 3, 2006
States' emergency orders regarding the 2004-05 influenza vaccine shortageMichael A Gaglia, Matthew M Davis
Vaccine|April 7, 2005
Associations of daycare and school entry vaccination requirements with varicella immunization ratesMatthew M Davis, Michael A Gaglia
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2014
Glycoprotein IIb/IIIa inhibitors increase bleeding: the elephant in the cardiac catheterization laboratoryMichael A Gaglia
Heart (British Cardiac Society)|July 25, 2014
Ticagrelor and the prevention of cardiovascular mortality: more than just platelet inhibition?Michael A Gaglia
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 17, 2017
Warfarin Prophylaxis for Anterior Infarction: Another Black Mark for Triple TherapyMichael A Gaglia
Circulation|January 19, 2011
Overview of the 2010 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding ticagrelorMichael A Gaglia, Ron Waksman
Cardiovascular Therapeutics|March 30, 2010
Proton pump inhibitors and clopidogrelMichael A Gaglia, Ron Waksman
Evidence-Based Medicine|October 23, 2012
Lack of association between proton pump inhibitors and adverse events in patients taking clopidogrel and aspirinRon Waksman, Michael A Gaglia
European Heart Journal|August 2, 2011
Systematic review of thienopyridine discontinuation and its impact upon clinical outcomesMichael A Gaglia, Ron Waksman
Journal of Cardiovascular Pharmacology and Therapeutics|September 24, 2013
Cardiovascular pharmacology core reviews: aspirinMichael A Gaglia, Leonardo Clavijo
Human Vaccines|October 3, 2006
States' emergency orders regarding the 2004-05 influenza vaccine shortageMichael A Gaglia, Matthew M Davis
Vaccine|April 7, 2005
Associations of daycare and school entry vaccination requirements with varicella immunization ratesMatthew M Davis, Michael A Gaglia
Pageof 8